Jennifer Markarian

Isolators move into smaller-volume processes, including cell and gene therapy manufacturing.

Disposable equipment components find use in small-volume aseptic biopharmaceutical manufacturing.

A new GMP facility in Raleigh, NC, and a starting materials facility in Paris, France, give Cellectis end-to-end, in-house manufacturing capacity for its UCART product candidates.

Mechanistic models provide process understanding for developing robust manufacturing processes and for scale up and tech transfer.

Models of biopharmaceutical processes can be used for speeding development and improving process control.

Material properties play a role in container closure integrity under frozen or cryogenic storage temperatures.

Packaging materials, kit design, and cold-chain handling should be optimized for each study.

Homology Medicines discusses how the clinical-stage biopharmaceutical company met its need for supply of adeno-associated virus vectors.

BioPharm International interviewed Cloudleaf about trends in tracking vaccines through the supply chain.

Packaging and transporting large quantities of COVID-19 vaccines pose challenges for the cold chain.